Farnesyltransferase Inhibitors and Rapamycin in the Treatment of Multiple Myeloma

E-ISSN： 1873-4316|7|6|449-453

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.7, Iss.6, 2006-12, pp. : 449-453

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Insights into the Treatment of Multiple Myeloma with Histone Deacetylase Inhibitors

Current Pharmaceutical Design, Vol. 19, Iss. 4, 2013-02 ,pp. : 734-744

Bentham Science Publishers

Access to resources Recommend Favorite

Farnesyltransferase Inhibitors: Potential Role in the Treatment of Cancer

By Cox A.D.

Drugs, Vol. 61, Iss. 6, 2001-01 ,pp. : 723-732

Adis International

Access to resources Recommend Favorite

Panobinostat for the treatment of multiple myeloma

By Neri Paola Bahlis Nizar J Lonial Sagar

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 5, 2012-05 ,pp. : 733-747

Informa Healthcare

Access to resources Recommend Favorite

Interferon-Alpha in the Treatment of Multiple Myeloma

Current Drug Targets, Vol. 12, Iss. 3, 2011-03 ,pp. : 437-446

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Treatment of Multiple Myeloma

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 5, 2006-10 ,pp. : 381-393

Bentham Science Publishers

Access to resources Recommend Favorite